Refine by
3d Bioprinted Articles & Analysis: Older
27 news found
Matexcel, a leading innovator in advanced materials and bioengineering, today announced its diverse portfolio of bio-ink products, empowering researchers across various fields to unlock the potential of 3D bioprinting. This comprehensive range, featuring tailored bio-inks for specific applications, paves the way for revolutionary advancements in regenerative ...
ByMatexcel
Under her leadership CELLINK continued to be a driving force in fostering collaboration in the bioprinting space by opening Centres of Excellence at leading institutions in the USA, India, and Singapore as well as establishing strategic partnerships with other commercial organizations to further advance bioprinting. ...
ByCELLINK
We are very excited to be working alongside CELLINK, leveraging their leading position in the 3D bioprinting Industry while also keeping close communication on future material and devices that can support our long-term vision of producing patient matched bone implants,” said Thea Wulff Olesen, CEO Ossiform. ...
ByCELLINK
“CELLINK Vivoink represents a major milestone in bioprinting technology,” said Cecilia Edebo, CEO of CELLINK. “We are proud to be at the forefront of innovation in the field of regenerative medicine and tissue engineering, and we believe that CELLINK Vivoink will empower researchers to take significant steps toward clinical applications of ...
ByCELLINK
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. ...
ByCELLINK
Carcinotech has established itself as a leader in producing 3D bioprinted Micro-Tumors as well as 3D models based on cancer cell lines, incorporating CELLINK’s technology for automated workflows that have been perfected over the last 3 years. ...
ByCELLINK
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The groundbreaking reconstructive procedure in the first-in-human ...
By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. ...
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust portfolio of bioprinters, utilizing extrusion based, 2PP and DLP technologies. BICO has acquired all the shares in San Diego-based Allegro ...
BICO Biosciences was awarded an impressive 4 awards in total (Discover Echo 2, Cytena BPS 2), 2 awards were awarded to companies in BICO Bioautomation (Scienion, Cellenion) and the final award was picked up by BICO Bioprinting (Nanoscribe). “We are thrilled to be recognized by the iF committee again this year. ...
This strategic expansion from MatTek aligns with the BICO Group’s strategy to increase accessibility to more sustainable solutions for drug testing and reducing the overall dependency on animal models. “Within the BICO Bioprinting Business Area we are seeing consistent growth in demand for tissue models and alternatives to animal testing. ...
The objective is now to start the first clinical trial of a 3D printed human tissue. Poietis, a pioneer in bioprinting, and the Assistance Publique – Hôpitaux de Marseille (« AP-HM ») announced today the installation of the first bioprinting platform compatible with the regulatory ...
ByPoietis
Presentation will highlight the development of functional 3D bioprinted co-cultured human hepatocyte spheroids for use as a liver tissue therapeutic Vancouver, BC, Canada, November 3, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, will present new data on its ...
Aspect Biosystems, a privately held biotechnology company pioneering the development of bioprinted therapeutics, is pleased to announce a new joint development program with JSR Corporation, a global leader in advanced materials innovation. This collaboration builds on the existing partnership between the two companies and will see the combining of Aspect’s proprietary ...
The results obtained with advanced 3D cell assays can better predict the drug performance in reality which isn’t revealed until after years in the clinical tests with patients. ...
ByUPM
Conventional shipping methods often involve storing cells and tissues in liquid nitrogen or dry ice, which requires a freeze-thaw process notorious for damaging biological material. Therefore, the global bioprinting community will greatly benefit from Atelerix products that allow for room-temperature storage and shipping of sensitive primary cells, iPSC-derived cells, ...
Aspect Biosystems, a biotechnology company developing bioprinted therapeutics, is pleased to announce the appointment of Ray Smith as its new Chief Financial Officer. ...
“This is such an exciting time for BIOLIFE4D, and I’m thrilled to accept the challenge of leading the Company into its first growth stage, toward commercialization of our pioneering 3D bioprinting technologies,” said Lewis. “From treatments like valve replacement and cardiac patches, to full-on heart transplants, to clinical research and ...
“3D bioprinting is a once-in-a-generation transformative technology. By focusing its 3D printing platform on a clinical application of high unmet need, Poietis is leading the adoption of 3D printing in cell therapy and tissue engineering” comments Dr. ...
ByPoietis
3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced it has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear in patients with microtia. ...